OP0314 Interferon score as a novel trial enrichment tool to predict clinical outcomes in patients with limited cutaneous systemic sclerosis

DI Donato, S., Ross, R., Karanth, R. et al. (6 more authors) (2024) OP0314 Interferon score as a novel trial enrichment tool to predict clinical outcomes in patients with limited cutaneous systemic sclerosis. In: EULAR 2024 European Congress of Rheumatology, 12-15 Jun 2024, Vienna, Austria.

Metadata

Item Type: Conference or Workshop Item
Authors/Creators:
Keywords: Biomedical and Clinical Sciences; Clinical Sciences; Clinical Research; Rare Diseases; Scleroderma; Precision Medicine; Biotechnology; Autoimmune Disease; Clinical Trials and Supportive Activities; Pharmaceuticals; Evaluation of markers and technologies; Neurological
Dates:
  • Published: 10 June 2024
  • Published (online): 10 June 2024
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Institute of Rheumatology & Musculoskeletal Medicine (LIRMM) (Leeds) > Inflammatory Arthritis (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 25 Sep 2024 12:26
Last Modified: 25 Sep 2024 12:26
Published Version: https://ard.bmj.com/content/83/Suppl_1/167.2
Status: Published
Publisher: BMJ
Identification Number: 10.1136/annrheumdis-2024-eular.4943
Open Archives Initiative ID (OAI ID):

Download not available

A full text copy of this item is not currently available from White Rose Research Online

Export

Statistics


CORE (COnnecting REpositories)